DOC vs JAN vs SBRA Stock Comparison

Healthpeak Properties, Janus Living and Sabra Health Care REIT Prices as of Nov 13, 2026 Peers: Industry group
JAN Janus Living, Inc.
$31.82 +9.8% 1M
Market cap
$7.46B
P/E
–
Revenue (TTM)
$835.56M
Div. yield
1.29%
Healthcare REITs Real Estate

Head to Head

12 decided of 12

Sabra Health Care REIT leads on 7 of the 12 questions below (Sabra Health Care REIT 7, Healthpeak Properties 5). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionDOCJANSBRALeader
Larger companyMarket capitalisation $13.78B $7.46B $5.35B DOC
Cheaper on earningsLower P/E, profitable companies only 36.5x -3,327x 73.1x DOC
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 318.2x 53.8x SBRA
Faster revenue growthRevenue growth, trailing twelve months +9.4% — +23.4% SBRA
More profitableNet margin, trailing twelve months 12.3% -0.3% 7.8% DOC
Better return on capitalReturn on invested capital -7.1% -21.2% 4.4% SBRA
Less leveragedLower net debt / EBITDA -962.8x — 2.9x DOC
Higher dividend yieldTrailing dividend yield 6.54% 1.29% 7.34% SBRA
Better 1-year returnPrice return, last 12 months +14.2% — +9.4% DOC
Better 5-year returnAnnualised price return, 5 years -10.0%/yr — +6.7%/yr SBRA
Less volatileAnnualised volatility, 1 year 28.6% 28.9% 24.8% SBRA
Higher overall scoreMean of the five percentile scores vs peers 46/100 25/100 50/100 SBRA

Percentile Scorecard

DOCJANSBRA

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisDOCJANSBRA
Valuation 34 #99 of 149 1 #147 of 149 40 #90 of 149
Growth 45 #82 of 147 – 51 #73 of 147
Profitability 43 #83 of 144 26 #107 of 144 56 #64 of 144
Financial Health 58 #63 of 149 72 #43 of 149 85 #24 of 149
Shareholder Returns 50 #70 of 139 2 #136 of 139 17 #115 of 139
Overall 46 25 50
  • DOC ranked among 150 companies in Property REITs
  • JAN ranked among 150 companies in Property REITs
  • SBRA ranked among 150 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodDOCJANSBRASPY
1 month +6.7%+9.8%+6.6% -2.0%
3 months -3.8%+3.9%+0.6% -2.8%
6 months +3.3%+19.3%-1.1% +2.0%
Year to date +24.3%—+7.9% +10.6%
1 year +14.2%—+9.4% +12.2%
3 years +18.0%—+40.5% +68.1%
3 years, per year +5.7%—+12.0% +18.9%
5 years -40.9%—+38.6% +61.4%
5 years, per year -10.0%—+6.7% +10.1%
10 years -28.9%—-0.2% +248.5%
10 years, per year -3.3%—0.0% +13.3%

Risk

MeasureDOCJANSBRASPY
Volatility, 1Y 28.6%28.9%24.8% 13.6%
Downside volatility, 1Y 24.1%26.9%22.5% 13.9%
Beta vs S&P 500, 1Y 0.34-0.01-0.13 1.00
Return / volatility, 1Y 0.49—0.38 0.90
Max drawdown, 5Y -57.6%-13.8%-38.7% -25.4%
From 52-week high -12.4%-3.2%-8.7% -3.2%
52-week high $22.83$32.88$22.39 $779.14
52-week low $15.78$22.88$17.67 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleDOCJANSBRA
P/E now vs peer median 36.5xmedian 26.1x -3,327xmedian 26.1x 73.1xmedian 26.1x
P/S now vs peer median 4.5xmedian 4.3x 8.9xmedian 4.3x 5.8xmedian 4.3x
EV/EBITDA now vs peer median -3,321xmedian 14.5x -10.9xmedian 14.5x 15.7xmedian 14.5x
P/FCF now vs peer median -6.0xmedian 21.4x -3.5xmedian 21.4x -16.4xmedian 21.4x
P/B now vs peer median 1.3xmedian 1.2x 1.8xmedian 1.2x 1.9xmedian 1.2x
PEG now vs peer median 4.77median 1.75 —median 1.75 1.85median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsDOCJANSBRA
Revenue $3.06B $835.56M $919.09M
Gross profit $1.74B – –
Operating income -$1.20B -$871.49M –
Net income $443.23M $38.54M $71.46M
Free cash flow -$2.30B -$2.15B -$325.53M
EPS (diluted) $0.55 $-0.01 $0.28
Cash & equivalents $514.31M $338.06M $36.24M
Total debt $6.14B – $1.24B
Shares (diluted) 689.51M 225.97M 259.82M
Enterprise value $12.92B $5.61B $4.90B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricDOCJANSBRA
P/E 36.5x -3,327x 73.1x
P/FCF -6.0x -3.5x -16.4x
P/Operating cash flow 10.8x 30.0x 13.4x
P/S 4.5x 8.9x 5.8x
P/B 1.3x 1.8x 1.9x
P/Tangible book 1.4x 2.0x 1.9x
EV/EBITDA -3,321x -10.9x 15.7x
EV/EBIT -16.2x -8.2x 36.1x
EV/Revenue 6.3x 8.5x 7.1x
EV/FCF -8.4x -3.3x -20.1x
EV/Operating cash flow 15.3x 28.7x 16.4x
PEG (3Y EPS CAGR) 4.77 – 1.85

Growth

14 metrics
MetricDOCJANSBRA
Revenue growth (1Y) 9.4% – 23.4%
Revenue CAGR (3Y) 12.5% – 12.3%
Gross profit growth (1Y) 3.4% – –
Gross profit CAGR (3Y) 11.6% – –
Operating income growth (1Y) -83.3% – –
Operating income CAGR (3Y) -92.0% – –
Net income growth (1Y) 2,652% – -59.2%
Net income CAGR (3Y) 17.9% – 41.1%
EPS growth (1Y) 1,076% – -61.7%
EPS CAGR (3Y) 7.7% – 39.6%
Operating cash flow growth (1Y) 2.3% – 17.4%
Operating cash flow CAGR (3Y) 10.9% – 11.4%
Free cash flow growth (1Y) -787.4% – -1,239%
Free cash flow CAGR (3Y) -326.3% – -59.7%

Profitability

14 metrics
MetricDOCJANSBRA
Gross margin 56.8% – –
EBITDA margin -0.2% -78.3% 45.3%
Operating margin -39.2% -104.3% –
Pretax margin 13.5% 4.7% 7.1%
Net margin 12.3% -0.3% 7.8%
FCF margin -75.1% -257.6% -35.4%
Operating cash flow margin 41.5% 29.7% 43.6%
Return on equity 4.2% 1.0% 2.5%
Return on assets 1.9% 0.8% 1.3%
Return on invested capital -7.1% -21.2% 4.4%
Return on capital employed – – –
Asset turnover 0.1x 0.2x 0.2x
Cash conversion (OCF / net income) 2.9x 6.4x 5.6x
Stock comp / revenue 0.6% 0.1% 1.5%

Financial Health

11 metrics
MetricDOCJANSBRA
Debt / assets 27.4% – 22.8%
Debt / equity 0.6x – 0.4x
Net debt / EBITDA -962.8x – 2.9x
Debt / FCF -2.7x – -3.8x
Liabilities / assets 51.9% 21.0% 47.7%
Equity / assets 48.1% 79.0% 52.3%
Interest coverage -14.7x -407.8x 1.6x
Current ratio – – –
Quick ratio – – –
Cash ratio – – –
Altman Z-score – – –

Shareholder Returns

7 metrics
MetricDOCJANSBRA
Dividend yield 6.5% 1.3% 7.3%
Net buyback yield 0.7% -11.2% -3.8%
Shareholder yield 7.3% -9.9% 3.5%
Payout ratio (earnings) 190.5% – 423.7%
Payout ratio (FCF) -36.7% – -93.0%
Dividend growth (1Y) 0.3% – -6.0%
Dividend CAGR (3Y) -8.9% – -3.0%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusDOCJANSBRA
Forward P/E – 318.2xFY2026 53.8xFY2026
EPS, next fiscal year – $0.10FY2026 $0.38FY2026
EPS growth, next FY – +150.0%FY2026 -40.6%FY2026
EPS growth, the year after – -10.0% +94.7%
Revenue, next fiscal year $2.86BFY2026 $885.94MFY2026 $882.92MFY2026
Revenue growth, next FY +3.7%FY2026 +27.8%FY2026 +14.0%FY2026
Revenue growth, the year after +12.9% +42.3% +14.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersDOCJANSBRA
Held by institutions 95.7% 38.1% 100.0%
Institutions holding 761 162 464
Change in shares held, QoQ -2.9% +56.8% +0.7%
Institutions buying 341 137 229
Institutions selling 314 19 147
Buyers to sellers 1.09 7.21 1.56

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

DOCJANSBRA
DOC 1.00 0.35 0.37
JAN 0.35 1.00 0.54
SBRA 0.37 0.54 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, DOC, JAN and SBRA?

Healthpeak Properties (DOC) is the largest by market capitalisation: Healthpeak Properties (DOC) $13.78B, Janus Living (JAN) $7.46B, Sabra Health Care REIT (SBRA) $5.35B.

Which stock is cheaper, DOC, JAN and SBRA?

Healthpeak Properties (DOC) trades on the lowest price-to-earnings ratio (Healthpeak Properties (DOC) 36.5x, Janus Living (JAN) -3,327x, Sabra Health Care REIT (SBRA) 73.1x). On next year's consensus earnings, Sabra Health Care REIT (SBRA) is cheapest (Janus Living (JAN) 318.2x, Sabra Health Care REIT (SBRA) 53.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Sabra Health Care REIT (SBRA) grew revenue fastest over the trailing twelve months: Healthpeak Properties (DOC) +9.4%, Sabra Health Care REIT (SBRA) +23.4%.

Which company is more profitable?

Healthpeak Properties (DOC) has the highest net margin (Healthpeak Properties (DOC) 12.3%, Janus Living (JAN) -0.3%, Sabra Health Care REIT (SBRA) 7.8%). On return on invested capital, Sabra Health Care REIT (SBRA) leads (Healthpeak Properties (DOC) -7.1%, Janus Living (JAN) -21.2%, Sabra Health Care REIT (SBRA) 4.4%).

Which stock has performed better?

Over the past year Healthpeak Properties (DOC) returned the most: Healthpeak Properties (DOC) +14.2%, Sabra Health Care REIT (SBRA) +9.4%. Over five years, Sabra Health Care REIT (SBRA) compounded fastest (Healthpeak Properties (DOC) -10.0%/yr, Sabra Health Care REIT (SBRA) +6.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Sabra Health Care REIT (SBRA) has the highest dividend yield: Healthpeak Properties (DOC) 6.54%, Janus Living (JAN) 1.29%, Sabra Health Care REIT (SBRA) 7.34%.

Which stock is riskier?

By one-year price volatility, Sabra Health Care REIT (SBRA) has been the steadiest (Healthpeak Properties (DOC) 28.6%, Janus Living (JAN) 28.9%, Sabra Health Care REIT (SBRA) 24.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, DOC, JAN and SBRA?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Sabra Health Care REIT (SBRA) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.